Intrepid Financial Planning Group »

Actinium Pharmaceuticals shares owned by Intrepid Financial Planning Group

Quarter-by-quarter ownership of Actinium Pharmaceuticals (ATNM) shares owned by Intrepid Financial Planning Group from 13F filings

Historical chart of Intrepid Financial Planning Group investment in Actinium Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Actinium Pharmaceuticals held by Intrepid Financial Planning Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actinium Pharmaceuticals by Intrepid Financial Planning Group

Quarter filed Position value Share count Share price at filing
2023-09-30 $107k 18k 5.92
2023-06-30 $134k 18k 7.42
2023-03-31 $180k 19k 9.45
2022-12-31 $213k 20k 10.65
2022-09-30 $148k 20k 7.40
2022-06-30 $96k 20k 4.80

More positions owned by Intrepid Financial Planning Group

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Exch Traded Fd Tr Ii Pfd Etf (PGX)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Select Sector Spdr Tr Technology (XLK)
Eli Lilly & Co. (LLY)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Select Sector Spdr Tr Energy (XLE)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares U S Etf Tr Bloomberg Roll (CMDY)
JPMorgan Chase & Co. (JPM)
Northwest Bancshares (NWBI)
Select Sector Spdr Tr Indl (XLI)

View all positions for Intrepid Financial Planning Group

Top funds holding Actinium Pharmaceuticals

Vanguard Group
Dimensional Fund Advisors
Brandywine Global Investment Management
Citadel Advisors
Charles Schwab Investment Management
Bank of New York Mellon
Royce & Associates
Bank of America Corporation
Barclays
Rhumbline Advisers
UBS Group
Jane Street
Creative Financial Designs
Virtu Financial
Jpmorgan Chase & Co

View all funds holding Actinium Pharmaceuticals